Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
GLP-1 Agonists Do Not Pose GI Cancer Risk
TOPLINE: Glucagon-like peptide-1 (GLP-1) receptor agonists used therapeutically for diabetes and weight loss do not elevate gastrointestinal (GI) cancer risk, according to a new meta-analysis by Italian investigators of 90 randomised clinical trials (RCTs) with nearly 125,000 participants. METHODOLOGY: This…
English